1. Need. Many patients with chronic neuropathic pain due to spinal cord injury (SCI) experience long-term suffering and have no recourse to adequate alternative therapy. Analgesic drugs are at best of weak or inconsistent efficacy for a given patient and can produce serious side effects at typical doses. This clinical trial is therefore qualitatively different from trials comparing some improved drug (etc.) with a currently used one.